Comparative analysis of NSG and NBSGW mice for preclinical evaluation of gene-modified human hematopoietic stem and progenitor cells

By afschroeder • April 17, 2026

Kuo CY, Harrington S, Campo-Fernandez B, Wyman SK, Wu X, Zhang R, Espinoza A, de Andrade Silva BJ, Sanchez JM, Fitz-Gibbon S, Tseng CH, Pellegrini M, Bonner M, Romero Z. Comparative analysis of NSG and NBSGW mice for preclinical evaluation of gene-modified human hematopoietic stem and progenitor cells. Stem Cell Res Ther. 2026 Apr 15. doi: 10.1186/s13287-026-05010-8. Epub ahead of print. PMID: 41987334.

Tags: CRISPR/Cas9, Dermatology, General Internal Medicine, Hematopoietic stem and progenitor cells (HSPCs), Humanized mouse models, Lentiviral vector (LVV), Long-term engraftment, Publications

ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtype

Assan F, Tragin M, Marella S, Lipecka J, Roger K, Zarhrate M, Bondet V, Nguyen V, Akroun F, Nitschké P, Guerrera IC, Bole C, Izmiryan[...]

A practical inflammatory blood-cell marker for cardiovascular risk stratification in psoriasis: Development of the Platelet-Leukocyte Adjusted Cardiovascular (PLAC) score

Cortes JA, Aflatooni S, Ure A, Palma G, Johnsen N, Smart K, Nong Y, Armstrong AW. A practical inflammatory blood-cell marker for cardiovascular risk stratification[...]

Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials

Stein Gold L, Armstrong AW, Soung J, Vender RB, González Cantero Á, Hoffmann M, Guenthner ST, Hong HC, Murrell DF, Song EJ, Kircik L, Augustin[...]